Libman-Sacks endocarditis
Endocarditis · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Non-bacterial (verrucous) valvular vegetations, classically with SLE or antiphospholipid syndrome, causing embolism and valve dysfunction without infection.
Figures & algorithms
Red flags
- Embolic stroke or systemic embolism
- Severe valvular regurgitation
- Positive blood cultures suggesting superimposed infection
- Heart failure
Assessment
Differential diagnosis
- Infective endocarditis
- Marantic (cancer-associated) endocarditis
- Rheumatic valve disease
- Valve fibroelastoma
- Antiphospholipid valvulopathy
Investigations
- Blood cultures (to exclude infection)
- Transthoracic then transoesophageal echocardiography
- Antiphospholipid antibodies and lupus serology
- Inflammatory markers
- Imaging for embolic events if symptomatic
Management
- Exclude infective endocarditis with cultures
- Assess for embolic phenomena (stroke, limb ischaemia)
- Anticoagulate, especially with antiphospholipid syndrome
- Treat underlying autoimmune disease
- Cardiology / rheumatology referral
- Surgery for severe valve dysfunction
Drugs & doses
Therapeutic anticoagulation
Immunosuppression for active SLE (specialist)
Antiplatelet where anticoagulation contraindicated
Disposition
Admit; cardiology and rheumatology.
Complications & pitfalls
- Thromboembolism
- Valve destruction / regurgitation
- Secondary infective endocarditis
Exam pearls
- Persistently negative cultures with vegetations plus autoimmune disease point to Libman-Sacks.
- Antiphospholipid syndrome greatly raises embolic risk.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.
